Short Interest in 111, Inc. Sponsored ADR (NASDAQ:YI) Drops By 45.1%
by Doug Wharley · The Cerbat Gem111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totaling 13,805 shares, a decline of 45.1% from the April 15th total of 25,129 shares. Currently, 0.3% of the company’s stock are short sold. Based on an average trading volume of 11,742 shares, the short-interest ratio is presently 1.2 days.
Analyst Ratings Changes
Separately, Weiss Ratings lowered 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 7th. One analyst has rated the stock with a Sell rating, According to MarketBeat, 111 currently has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on 111
111 Price Performance
111 stock traded up $0.02 during mid-day trading on Monday, reaching $5.81. 20,136 shares of the company traded hands, compared to its average volume of 34,766. The firm’s fifty day moving average is $6.50 and its two-hundred day moving average is $5.50. The company has a market capitalization of $51.08 million, a price-to-earnings ratio of -5.81 and a beta of 0.66. 111 has a fifty-two week low of $2.48 and a fifty-two week high of $11.17.
About 111
111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.
111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.